FDA Initiates Formation of a New Advisory Committee for Digital Health Technologies | Cromos Pharma
FDA Initiates Formation of a New Advisory Committee for Digital Health Technologies The FDA has introduced a fresh initiative in the form of the Digital Health Advisory Committee. This committee’s primary objective is to assist the FDA in exploring the intricate scientific and technical aspects of digital health technologies (DHTs), encompassing domains such as artificial intelligence/machine learning, augmented reality, virtual reality, digital therapeutics, wearables, remote patient monitoring,
Happy Labor Day from Cromos Pharma Team
Happy Labor Day 2023 On this special day, we celebrate the hard work and dedication of workers everywhere. It’s a time to relax, unwind, and enjoy the fruits of your labor.   From Cromos Pharma, we wish you a delightful Labor Day filled with relaxation, joy, and quality time with loved ones.   May this day rejuvenate you for
Cromos Pharma commences a pivotal multicountry clinical trial of OT-101 in patients with advanced pancreatic cancer.
Cromos Pharma commences a pivotal multicountry clinical trial of OT-101 in patients with advanced pancreatic cancer Cromos Pharma is thrilled to announce the commencement of a pivotal trial, focused on the investigation of OT-101, a collaborative effort between Oncotelic  Therapeutics and Sapu Bioscience, in individuals suffering from advanced and unresectable or metastatic pancreatic cancer. With this ambitious multicountry endeavor, Cromos Pharma’s aspiration is to deliver a long-awaited enhancement in survival outcomes

Schedule a meeting

We are excited to connect with you, understand your goals, and explore how we can support your needs.

Contact us